Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival.

Chalour N, Maoui A, Rat P, Massicot F, Dutot M, Faussat AM, Devevre E, Limb A, Warnet JM, Treton J, Dinet V, Mascarelli F.

Curr Alzheimer Res. 2018;15(7):643-654. doi: 10.2174/1567205015666180119101832.

PMID:
29357794
2.

Correlation between aqueous flare and chorioretinal neovascularization in age-related macular degeneration following intravitreal bevacizumab injections.

Errera MH, Girmens JF, Ayello-Scheer S, Nourry H, Warnet JM, Sahel JA, Barale PO.

J Fr Ophtalmol. 2014 Jan;37(1):30-5. doi: 10.1016/j.jfo.2013.02.008. Epub 2013 Oct 24.

3.

RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies.

Brignole-Baudouin F, Warnet JM, Barritault D, Baudouin C.

J Fr Ophtalmol. 2013 Nov;36(9):740-7. doi: 10.1016/j.jfo.2013.01.012. Epub 2013 Aug 16.

4.

Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight.

Ghazi K, Deng-Pichon U, Warnet JM, Rat P.

PLoS One. 2012;7(11):e48351. doi: 10.1371/journal.pone.0048351. Epub 2012 Nov 16.

5.

In vitro interactions between peripheral blood lymphocytes and the Wong-Kilbourne derivative of Chang conjunctival cells.

Chassignol A, Brasnu E, Baudouin C, Riancho L, Warnet JM, Brignole-Baudouin F.

Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1492-8. doi: 10.1167/iovs.11-7708.

PMID:
22328639
6.

[A relevant choice for corticoid eye drops: solution or suspension?].

Nourry H, Viard C, Cambourieu C, Warnet JM.

J Fr Ophtalmol. 2011 Dec;34(10):691-6. doi: 10.1016/j.jfo.2011.04.013. Epub 2011 Oct 15. French.

7.

Does modulation of organic cation transporters improve pralidoxime activity in an animal model of organophosphate poisoning?

Kayouka M, Houzé P, Baud FJ, Cisternino S, Debray M, Risède P, Schinkel AH, Warnet JM.

Crit Care Med. 2011 Apr;39(4):803-11. doi: 10.1097/CCM.0b013e318206d52f.

PMID:
21242797
8.

[Preservatives in eye drops: toward awareness of their toxicity].

Vaede D, Baudouin C, Warnet JM, Brignole-Baudouin F.

J Fr Ophtalmol. 2010 Sep;33(7):505-24. doi: 10.1016/j.jfo.2010.06.018. Epub 2010 Sep 15. Review. French.

9.

Multipurpose solutions and contact lens: modulation of cytotoxicity and apoptosis on the ocular surface.

Dutot M, Reveneau E, Pauloin T, Fagon R, Tanter C, Warnet JM, Rat P.

Cornea. 2010 May;29(5):541-9. doi: 10.1097/ICO.0b013e3181bd4bc1.

PMID:
20418717
10.

Per os administered refined olive oil and marine PUFA-rich oils reach the cornea: possible role on oxidative stress through caveolin-1 modulation.

Dutot M, Liang H, Martin C, Rousseau D, Grynberg A, Warnet JM, Rat P.

Nutr Metab (Lond). 2009 Nov 23;6:48. doi: 10.1186/1743-7075-6-48.

11.

Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects.

Pauloin T, Dutot M, Liang H, Chavinier E, Warnet JM, Rat P.

Cornea. 2009 Oct;28(9):1032-41. doi: 10.1097/ICO.0b013e3181a0a3f8.

PMID:
19724206
12.

High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells.

Pauloin T, Dutot M, Joly F, Warnet JM, Rat P.

Mol Vis. 2009;15:577-83. Epub 2009 Mar 23.

13.

Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage.

Pauly A, Meloni M, Brignole-Baudouin F, Warnet JM, Baudouin C.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1644-52. doi: 10.1167/iovs.08-2992. Epub 2009 Jan 24.

PMID:
19168896
14.

[Oxidative stress modulation using polyphenol-rich blueberries: application on a human retinal cell model].

Dutot M, Rambaux L, Warnet JM, Rat P.

J Fr Ophtalmol. 2008 Dec;31(10):975-80. French.

15.

Ocular burn: rinsing and healing with ionic marine solutions and vegetable oils.

Said T, Dutot M, Labbé A, Warnet JM, Rat P.

Ophthalmologica. 2009;223(1):52-9. doi: 10.1159/000172618. Epub 2008 Nov 20.

PMID:
19023222
16.

In vivo confocal microscopic grading system for standardized corneal evaluation: application to toxic-induced damage in rat.

Pauly A, Labbe A, Baudouin C, Liang H, Warnet JM, Brignole-Baudouin F.

Curr Eye Res. 2008 Oct;33(10):826-38. doi: 10.1080/02713680802381460.

PMID:
18853316
17.

[Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy].

Chebbi CK, Kichenin K, Amar N, Nourry H, Warnet JM, Barritault D, Baudouin C.

J Fr Ophtalmol. 2008 May;31(5):465-71. French.

18.

In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride.

Pauloin T, Dutot M, Warnet JM, Rat P.

Eur J Pharm Sci. 2008 Aug 7;34(4-5):263-73. doi: 10.1016/j.ejps.2008.04.006. Epub 2008 May 1.

PMID:
18534829
19.

Effects of toxic cellular stresses and divalent cations on the human P2X7 cell death receptor.

Dutot M, Liang H, Pauloin T, Brignole-Baudouin F, Baudouin C, Warnet JM, Rat P.

Mol Vis. 2008 May 19;14:889-97.

20.

Severe ocular infections with contact lens: role of multipurpose solutions.

Dutot M, Paillet H, Chaumeil C, Warnet JM, Rat P.

Eye (Lond). 2009 Feb;23(2):470-6. doi: 10.1038/eye.2008.131. Epub 2008 May 16.

PMID:
18483496
21.

[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].

Errera MH, Barale PO, Nourry H, Zamfir O, Guez A, Warnet JM, Sahel JA, Chaumeil C.

J Fr Ophtalmol. 2008 Jan;31(1):62-6. French.

22.

In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.

Brasnu E, Brignole-Baudouin F, Riancho L, Guenoun JM, Warnet JM, Baudouin C.

Curr Eye Res. 2008 Apr;33(4):303-12. doi: 10.1080/02713680801971857.

PMID:
18398704
23.

Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits.

Liang H, Brignole-Baudouin F, Rabinovich-Guilatt L, Mao Z, Riancho L, Faure MO, Warnet JM, Lambert G, Baudouin C.

Mol Vis. 2008 Jan 31;14:204-16.

24.
25.

Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells.

Ezoulin MJ, Ombetta JE, Dutertre-Catella H, Warnet JM, Massicot F.

Neurotoxicology. 2008 Mar;29(2):270-7. doi: 10.1016/j.neuro.2007.11.004. Epub 2007 Nov 26.

PMID:
18191456
26.

Cytotoxicity of contact lens multipurpose solutions: role of oxidative stress, mitochondrial activity and P2X7 cell death receptor activation.

Dutot M, Warnet JM, Baudouin C, Rat P.

Eur J Pharm Sci. 2008 Feb 5;33(2):138-45. Epub 2007 Nov 6.

PMID:
18065213
27.

New tools for the evaluation of toxic ocular surface changes in the rat.

Pauly A, Brignole-Baudouin F, Labbé A, Liang H, Warnet JM, Baudouin C.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5473-83.

PMID:
18055795
28.

Benefits and side effects of different vegetable oil vectors on apoptosis, oxidative stress, and P2X7 cell death receptor activation.

Said T, Dutot M, Christon R, Beaudeux JL, Martin C, Warnet JM, Rat P.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5000-6.

PMID:
17962450
29.

Stimulation of anti-melanoma immune effectors via modified tumour cells exhibiting inhibited IGF-I and low CD9.

Trabado S, Van Binh PN, Martin C, Lafarge-Frayssinet C, Lone YC, Trojan J, Warnet JM, Duc HT.

Biomed Pharmacother. 2007 Sep;61(8):494-8. Epub 2007 Aug 7.

PMID:
17764889
30.

In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.

Baudouin C, Riancho L, Warnet JM, Brignole F.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4123-8.

PMID:
17724196
31.

Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice.

Noble F, Rubira E, Boulanouar M, Palmier B, Plotkine M, Warnet JM, Marchand-Leroux C, Massicot F.

Neurosci Lett. 2007 Sep 7;424(2):106-10. Epub 2007 Aug 1.

PMID:
17716817
32.

LPS-stimulated inflammation and apoptosis in corneal injury models.

Liang H, Brignole-Baudouin F, Labbé A, Pauly A, Warnet JM, Baudouin C.

Mol Vis. 2007 Jul 17;13:1169-80.

PMID:
17679944
33.

The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways.

Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F.

Ophthalmology. 2008 Jan;115(1):109-15. Epub 2007 May 29.

PMID:
17532048
34.

Cytoprotective effect against UV-induced DNA damage and oxidative stress: role of new biological UV filter.

Said T, Dutot M, Martin C, Beaudeux JL, Boucher C, Enee E, Baudouin C, Warnet JM, Rat P.

Eur J Pharm Sci. 2007 Mar;30(3-4):203-10. Epub 2006 Nov 9.

PMID:
17188472
35.

In vivo confocal microscopy and ex vivo flow cytometry: new tools for assessing ocular inflammation applied to rabbit lipopolysaccharide-induced conjunctivitis.

Liang H, Baudouin C, Labbé A, Pauly A, Martin C, Warnet JM, Brignole-Baudouin F.

Mol Vis. 2006 Nov 16;12:1392-402.

36.

Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cells.

Trabado S, Nguyen Van Binh P, Martin C, Lafarge-Frayssinet C, Thevenin M, Baudouin F, Warnet JM, Duc HT.

Biomed Pharmacother. 2006 Dec;60(10):693-7. Epub 2006 Oct 19.

PMID:
17071049
37.

[Role of conditioning medium cytotoxicity. An example with an intraocular lens preloaded in injector].

Staropoli A, Baudouin C, Dutot M, Sultan G, Warnet JM, Rat P.

J Fr Ophtalmol. 2006 Sep;29(7):773-80. French.

38.

Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study.

Labbé A, Pauly A, Liang H, Brignole-Baudouin F, Martin C, Warnet JM, Baudouin C.

J Ocul Pharmacol Ther. 2006 Aug;22(4):267-78.

PMID:
16910868
39.

Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles.

Pauly A, Brignole-Baudouin F, Guenoun JM, Riancho L, Rat P, Warnet JM, Baudouin C.

Graefes Arch Clin Exp Ophthalmol. 2007 Apr;245(4):534-46. Epub 2006 Aug 10.

PMID:
16900358
40.

Fluoroquinolone eye drop-induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis.

Dutot M, Pouzaud F, Larosche I, Brignole-Baudouin F, Warnet JM, Rat P.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2812-9.

PMID:
16799018
41.

Comparative anatomy of laboratory animal corneas with a new-generation high-resolution in vivo confocal microscope.

Labbé A, Liang H, Martin C, Brignole-Baudouin F, Warnet JM, Baudouin C.

Curr Eye Res. 2006 Jun;31(6):501-9.

PMID:
16769609
42.

Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells.

Pouzaud F, Dutot M, Martin C, Debray M, Warnet JM, Rat P.

Comp Biochem Physiol C Toxicol Pharmacol. 2006 Jun;143(2):232-41. Epub 2006 Mar 6.

PMID:
16574493
43.

[Cytotoxicity evaluation of different eyes drops with cyclosporine oral solution (Sandimmun)].

Nourry H, Perrot S, Martin C, Chaumeil C, Cambourieu C, Rat P, Warnet JM.

J Fr Ophtalmol. 2006 Mar;29(3):251-7. French.

44.

[Heavy silicone oil as internal tamponade for retinal detachment: efficacy and tolerance].

Scheer S, Boni S, Barale PO, Bourhis A, Bonnel S, Tuil E, Girmens JF, Buil O, Baudouin C, Laroche L, Nordmann JP, Poisson F, Warnet JM, Sahel JA.

J Fr Ophtalmol. 2006 Feb;29(2):129-35. French.

45.

[Activation of TH1/TH2 pathways detected through the expression of CCR4 and CCR5 on the ocular surface of glaucomatous patients treated over the long term].

Liang H, Baudouin C, Hamard P, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F.

J Fr Ophtalmol. 2006 Feb;29(2):121-6. French.

46.

In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.

Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F.

Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4594-9.

PMID:
16303954
47.

CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders.

Baudouin C, Liang H, Bremond-Gignac D, Hamard P, Hreiche R, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F.

J Allergy Clin Immunol. 2005 Sep;116(3):614-9.

PMID:
16159632
48.

In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.

Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F.

Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2444-50.

PMID:
15980234
49.

[Can Xylocaine gel be used as a cataract anesthetic?].

Auclin F, Boureau C, Warnet JM, Baudouin C.

J Fr Ophtalmol. 2005 May;28(5):533-4. French. No abstract available.

50.

[Postoperative endophthalmitis: 2000-2002 results in the XV-XX National Ophthalmologic Hospital].

Morel C, Gendron G, Tosetti D, Poisson F, Chaumeil C, Auclin F, Laplace O, Tuil E, Warnet JM.

J Fr Ophtalmol. 2005 Feb;28(2):151-6. French.

Supplemental Content

Loading ...
Support Center